Charles McDermott Email

Chairman/President/CEO . Primmune Therapeutics

San Diego, CA

Location

LinkedIn

Current Roles

Employees:
10
Revenue:
$775k
About
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
Primmune Therapeutics Address
3210 Merryfield Row
San Diego, CA
Primmune Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.